E-PaperCipla Q3 Results
- BSE: 500087
- NSE: CIPLA
- ISIN: INE059A01026
- Sector: Biotechnology & Drugs
BSE
1,483.5
-22.55 (-1.50%)
-22.55 (-1.50%)Volume16.45 K
Updated: Fri 19 Jul, 2024 | 15:29:54
NSE
1,485.5-21.15 (-1.40%)
-21.15 (-1.40%)Volume8.68 L
Updated: Fri 19 Jul, 2024 | 15:32:09
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Cipla Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 6,603.81 | 6,678.15 | -1.11% | 5,810.09 | 13.66% |
| Selling/ General/ Admin Expenses Total | 1,068.13 | 1,091.10 | -2.11% | 948.69 | 12.59% |
| Depreciation/ Amortization | 233.43 | 290.04 | -19.52% | 272.11 | -14.21% |
| Other Operating Expenses Total | 1,568.62 | 1,540.21 | 1.84% | 1,449.55 | 8.21% |
| Total Operating Expense | 5,284.53 | 5,234.44 | 0.96% | 4,674.65 | 13.05% |
| Operating Income | 1,319.28 | 1,443.71 | -8.62% | 1,135.44 | 16.19% |
| Net Income Before Taxes | 1,473.81 | 1,594.23 | -7.55% | 1,218.06 | 21.00% |
| Net Income | 1,055.90 | 1,130.91 | -6.63% | 800.96 | 31.83% |
| Diluted Normalized EPS | 14.82 | 14.00 | 5.85% | 9.92 | 49.38% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Buy or sell: Sumeet Bagadia recommends these three stocks to buy on Monday — July 22
4 min read10:11 AM IST - Markets
02Gold and silver prices today on 21-07-2024: Check latest rates in your city
2 min read10:15 AM IST - Markets
03RBI sells $406 million in Indian Bonds as Index Inclusion boosts inflows: Report
1 min read08:05 PM IST